Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.
about
Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory diseaseMutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).Parainfluenza virusesWheat germ cell-free system-based production of hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 for generation and characterization of monoclonal antibodyInhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entryInfluence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo.Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site.Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusionMutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase proteinPremature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machineryA second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.Detailed genetic analysis of hemagglutinin-neuraminidase glycoprotein gene in human parainfluenza virus type 1 isolates from patients with acute respiratory infection between 2002 and 2009 in Yamagata prefecture, JapanFusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and IIIsolation & molecular characterization of human parainfluenza virus in Chennai, IndiaA dual drug regimen synergistically blocks human parainfluenza virus infection.Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity.Kinetic dependence of paramyxovirus entry inhibition.Identification of a region in the stalk domain of the nipah virus receptor binding protein that is critical for fusion activation.Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.Amino acid substitutions in the F-specific domain in the stalk of the newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein.Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.Measles virus fusion machinery activated by sialic acid binding globular domain.Regulation of paramyxovirus fusion activation: the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state.The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion.Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein.Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells.Effects of hemagglutinin-neuraminidase protein mutations on cell-cell fusion mediated by human parainfluenza type 2 virus
P2860
Q24530163-AE7C0330-44CD-4569-B9D5-5B6D58C1A73AQ24540532-BBA54E4D-39CE-471C-AEAE-C1F1E3997174Q24682952-CDCDBAB2-8220-460C-BAB7-CA1B878FCADAQ33633800-E5169660-D79B-4601-A784-E704AF21F39EQ33741962-75A88AD5-DE1E-4F1F-BB0C-0C1EC68BDA0EQ33782736-240800A7-8CBD-4F30-8421-E1ADB9F45F82Q33870586-0C507BA9-21E1-474D-9E77-48C19C71926AQ34302118-41C1201E-CBB7-4304-A7B1-42B18E6DC67FQ34745220-99612FDB-C4D5-4390-8964-486EEAE15DCDQ35024321-88576B08-C421-4F1A-92A0-0C3C756EC18FQ35515383-E97BA57E-668D-40CC-B949-C50E3AF43D57Q35785169-8E840B57-7D7B-4D9C-80D8-C3B44C2EB28BQ35809070-A66D5D91-FA2F-4E22-A297-9F597ED7F3E3Q35948109-15AD85D2-5779-4DA6-B9C6-5C0111778F4EQ36550193-A2D8A841-E7E0-4BE1-8617-5D6502590E25Q36774468-91886659-FEC7-4E14-81F1-4C5D8CF57D34Q36845779-6345A5A8-DD13-4A92-8364-8AE665EB0EC4Q37232820-061C5755-B3AD-4438-8E0A-5DD47CDB883DQ37232863-FD8E891E-CF9D-4902-A275-BB295468A38BQ37252586-96366D1E-37CB-4BAB-A8B1-7226588AA688Q37333181-37FD353B-313D-40B5-8AF9-5C89660D1E8FQ37596488-33596062-B56F-48E5-8312-A89565E3CC99Q37683568-A26D35C3-2824-432F-B40E-A00A319B7922Q39083962-AC68083F-CAA1-4DA7-A5AB-C4A9F0E50E6AQ39275444-622C9057-60E5-43EB-803C-F09C4F60D6BEQ39375677-C9F54AA9-B5DF-40E6-8F33-E689659069F4Q39462591-12B4569E-1550-4E74-8E22-96F2FB27BDC5Q41039144-0C9538FB-43CF-428C-821A-13933F59C093Q42081316-F3FDE0AC-B97F-4B1C-88DA-70686BF92B06
P2860
Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Human parainfluenza virus type ...... uraminidase-deficient variant.
@ast
Human parainfluenza virus type ...... uraminidase-deficient variant.
@en
type
label
Human parainfluenza virus type ...... uraminidase-deficient variant.
@ast
Human parainfluenza virus type ...... uraminidase-deficient variant.
@en
prefLabel
Human parainfluenza virus type ...... uraminidase-deficient variant.
@ast
Human parainfluenza virus type ...... uraminidase-deficient variant.
@en
P2093
P2860
P1433
P1476
Human parainfluenza virus type ...... uraminidase-deficient variant.
@en
P2093
N Poltoratskaia
O Greengard
P2860
P304
P356
10.1128/JVI.75.16.7481-7488.2001
P577
2001-08-01T00:00:00Z